Related Experiment Video
Updated: Jul 5, 2026
07:37
An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
Quantifiable mRNA transcripts for tamoxifen-metabolising enzymes in human endometrium
Maneesh N Singh1, Helen F Stringfellow, Michael J Walsh
1Lancashire Teaching Hospitals NHS Trust, Fulwood, Preston, UK.
Toxicology
|May 27, 2008
Summary
Tamoxifen use increases endometrial cancer risk, potentially via genotoxic metabolites. Researchers found key enzyme gene expression in endometrial tissues, suggesting tamoxifen bioactivation may occur, but further study is needed.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Tamoxifen is a widely used treatment for receptor-positive breast cancer.
- Tamoxifen use is linked to an increased risk of endometrial carcinoma, including endometrioid and type 2/MESTs.
- The carcinogenic mechanism of tamoxifen in endometrial tissue, particularly regarding genotoxicity, is not fully understood.
Purpose of the Study:
- To investigate the expression of genes involved in tamoxifen metabolism and bioactivation in human endometrial tissues.
- To explore the potential for genotoxic tamoxifen metabolite generation in the endometrium.
Main Methods:
- Quantitative gene expression analysis using real-time RT-PCR.
- Examination of endometrial tissues from benign, non-tamoxifen-associated carcinoma, and tamoxifen-associated carcinoma groups.
- Assessed relative gene expression of metabolic enzymes CYP1A2, CYP1B1, CYP3A4, COMT, and SULT2A1.
Main Results:
- Measurable mRNA transcripts for genes associated with tamoxifen bioactivation were detected in all examined endometrial tissues.
- Gene expression levels varied across benign and cancerous endometrial tissues.
Conclusions:
- The presence of mRNA transcripts suggests that human endometrial tissue possesses the machinery for tamoxifen bioactivation.
- Further research is required to confirm whether genotoxic tamoxifen metabolites are indeed generated in the endometrium and contribute to tamoxifen-induced carcinogenicity.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...